NDC 69278-101 - Dr Cellapy SR Premium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 69278-101
- Package NDCs from labels
- 69278-101-01, 69278-101-02
- Manufacturer
- GM Holdings Co., Ltd
- Effective date
- 2020-01-21
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Dr. Cellapy SR Premium Solution - GM Holdings Co., Ltd | GM Holdings Co., Ltd | 2020-01-21 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69278-101-01 | Dr Cellapy SR Premium | 5 mL in 1 VIAL | LIQUID | 5 mL | 0.005 in 5mL | 6 |
| 69278-101-02 | Dr Cellapy SR Premium | 5 in 1 BOX | LIQUID | 0.005 in 5mL | 6 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Potassium Chloride | POTASSIUM CHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 471f3a39-5fea-cd7a-e063-6294a90a0d93 | 2025-12-29 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride for Oral Solution | POTASSIUM CHLORIDE FOR ORAL SOLUTION | Ajenat Pharmaceuticals LLC | c62c5704-3667-4d4f-8230-3f7f5ed825b1 | 2025-12-29 | Warnings, Adverse reactions | 660YQ98I10 |
| OCUFRESH | WATER | Optics Laboratory Inc. | b8e477a9-66b9-496b-92fb-3d4bbd7b36b5 | 2025-12-29 | Warnings | 059QF0KO0R |
| Kollourion Eyesalve Eyewash | PURIFIED WATER 98.3% | Miracle Eye Pharmaceuticals | b56d2ab9-169b-b490-e053-2a95a90a80b3 | 2025-12-28 | Warnings | 059QF0KO0R |
| Potassium Chloride | POTASSIUM CHLORIDE | Northwind Health Company, LLC | 0a72cc27-e092-d85a-e063-6294a90a503c | 2025-12-26 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | BPI Labs LLC | aeb2e14e-cd7c-49d0-a15f-fbbe89a03c6b | 2025-12-26 | Warnings, Adverse reactions | 660YQ98I10 |
| potassium chloride | POTASSIUM CHLORIDE | Redpharm Drug | 3735d41a-7787-6b92-e063-6294a90add45 | 2025-12-24 | Warnings, Adverse reactions | 660YQ98I10 |
| calcium chloride | CALCIUM CHLORIDE | Amneal Pharmaceuticals LLC | 7649c84f-f1c2-4169-962d-ccbac56523a9 | 2025-12-22 | Warnings, Adverse reactions | M4I0D6VV5M |
| Viru-Chord | BELLADONNA, CINCHONA OFFICINALIS, ECHINACEA (ANGUSTIFOLIA), GELSEMIUM SEMPERVIRENS, GLANDULA SUPRARENALIS SUIS, GLYCYRRHIZA GLABRA, HEPAR SUIS, HYDRASTIS CANADENSIS, ILLICIUM ANISATUM, INFLUENZINUM, LACHESIS MUTUS, LAPPA MAJOR, MAGNESIA PHOSPHORICA, MORBILLINUM, MYRRHA, NASTURTIUM AQUATICUM, NUX VOMICA, PALOONDO, PYRIDOXINUM HYDROCHLORICUM, RIBOFLAVINUM, SAMBUCUS NIGRA, SCUTELLARIA LATERIFLORA, THIAMINUM HYDROCHLORICUM, THYROIDINUM (BOVINE) | Energetix Corporation | 4a53b25e-f514-4d2d-8c2b-3c56d68ec7eb | 2025-12-22 | Warnings | TLM2976OFR |
| Endopath-M | ADENOSINUM CYCLOPHOSPHORICUM, AGNUS CASTUS, ASPARAGUS OFFICINALIS, AVENA SATIVA, CADMIUM METALLICUM, DAMIANA, GLANDULA SUPRARENALIS SUIS, JUNIPERUS COMMUNIS, LYCOPODIUM CLAVATUM, ORCHITINUM (BOVINE), PETROSELINUM SATIVUM, PITUITARUM POSTERIUM (BOVINE), PULSATILLA (VULGARIS), SABAL SERRULATA, SARSAPARILLA (SMILAX REGELII) | Energetix Corporation | ece117c4-5116-458e-888a-5ff3cf0cfbfb | 2025-12-22 | Warnings | E0399OZS9N |
| Hair and Nail Tonic | AVENA, DNA, ELAEIS, GLANDULA SUPRARENALIS SUIS, HAMAMELIS, HEPAR SUIS, KALI SULPH, NAT MUR, NICOTINAMIDUM, PHOSPHORICUM AC, PITUITARUM POSTERIUM, RIBOFLAVINUM, THIAMINUM HYDROCHLORICUM, THUJA OCC, THYROIDINUM, URTICA UR. | Eight and Company L.L.C | 35bda785-b3a7-4928-aaea-27bf9fb6abb5 | 2025-12-18 | Warnings | 25X51I8RD4 TLM2976OFR |
| Sterile Water | WATER | ProPharma Distribution | 386a0a2f-4ff7-f128-e063-6294a90a7d4d | 2025-12-18 | Warnings, Adverse reactions | 059QF0KO0R |
| POKONZA | POTASSIUM CHLORIDE | Carwin Pharmaceutical Associates, LLC | 0700c19e-abca-4527-8944-e4440a32e3af | 2025-12-18 | Warnings, Adverse reactions | 660YQ98I10 |
| Hepatatox | TRITICUM AESTIVUM, CHELIDONIUM MAJUS, TARAXACUM OFFICINALE, GLUTATHIONE, HEPAR SUIS, THYROIDINUM (SUIS), LYCOPODIUM CLAVATUM, NUX VOMICA, PHOSPHORICUM ACIDUM, ADRENOCORTICOTROPHIN, SALICYLICUM ACIDUM, CORTISONE ACETICUM, EUGENOL, STEARYL ALCOHOL, XYLITOL, FOLLICULINUM, BENZOICUM ACIDUM, CHLORINUM POTASSIUM SORBATE, SORBITOL, RESORCINUM, BENZYL ALCOHOL, LACTICUM ACIDUM, ISOPROPYL PALMITATE, BORICUM ACIDUM, ACETICUM ACIDUM, PHENYL BUTAZONE, PETROLEUM JELLY, PLUMBUM METALLICUM | BioActive Nutritional, Inc | a113a9f1-4792-41a5-8d1b-a6756f356e15 | 2025-12-18 | Warnings | GAN16C9B8O |
| STYE EYE RELIEF SERUM | VITAMIN E | Guangzhou Mizi Biotechnology Co., LTD. | 3f60193e-4b95-6759-e063-6394a90a991c | 2025-12-17 | Warnings | PQ6CK8PD0R 30KYC7MIAI 6BJQ43T1I9 K3Z4F929H6 |
| Circulopath | ADENOSINUM CYCLOPHOSPHORICUM, ARNICA MONTANA, AURUM MURIATICUM, BARYTA MURIATICA, BORAGO OFFICINALIS, CHOLESTERINUM, CITRUS LIMONUM, HYPOTHALAMUS (BOVINE), KALI IODATUM, LAUROCERASUS, MAGNESIA MURIATICA, NADIDUM, PHASEOLUS, PHOSPHORUS, THYROIDINUM (BOVINE) | Energetix Corporation | 448d5ea0-ca41-487a-8321-38b1667764bd | 2025-12-17 | Warnings | 0U46U6E8UK E0399OZS9N |
| ReHydration | ADENOSINUM CYCLOPHOSPHORICUM, COFFEA CRUDA, GLANDULA SUPRARENALIS SUIS, HYPOTHALAMUS, KALI PHOS, NAT MUR, SARSAPARILLA, SILICEA, TARAXACUM, THYROIDINUM | Energetix Corporation | 9b532a31-530a-44f9-843f-f395a3e460b8 | 2025-12-17 | Warnings | E0399OZS9N |
| Pediatric Earache Remedy | EAR DROPS | Vitality Works, Inc | 5769ce2c-d2e1-4069-92cc-e38bee668daf | 2025-12-17 | Warnings | 660YQ98I10 |
| OP-P | EMOTIONAL HEALTH BOOSTER | Vitality Works, Inc. | a8b87a49-fc73-4494-8dc9-059bc5f82d42 | 2025-12-17 | Warnings | 660YQ98I10 |
| Earache Remedy | EAR DROPS | Vitality Works, Inc. | 49afb2c3-ee42-4be9-943a-36d73ded0004 | 2025-12-17 | Warnings | 660YQ98I10 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.